基本情報
- CAS
22832-87-7- 標準SMILES
Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1.O=[N+]([O-])O- InChIKey
MCCACAIVAXEFAL-UHFFFAOYSA-N- 分子式
- C18H15Cl4N3O4
- 平均分子量
- 479.1 g/mol
- 単同位体質量
- 476.98166668
概要
Miconazole is an antifungal prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of mucocutaneouscandidiasis, including:
名称と識別子
- 優先名称
- Miconazole Nitrate
- IUPAC
- 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid
- 現地名
- 硝酸ミコナゾール
- 英語名
- Miconazole nitrate
- 分子式
- C18H14Cl4N2O.HNO3
- 分子量
- 479.14
名称と別名
名称をさらに表示
データベース識別子
- CAS
22832-87-7- PubChem CID
- 68553
- DTXSID
DTXSID50996767- ChEMBL
CHEMBL1559- UNII
- VW4H1CYW1K
- EC Number
- 245-256-6、922-010-2
物性
構造計算による物性
- 極性表面積
- 93.1 Ų
- 水素結合供与体数
- 1
- 水素結合受容体数
- 5
- 回転可能結合数
- 6
- 重原子数
- 29
- 形式電荷
- 0
- 複雑度
- 441
実験および物理化学的性質
Human Drugs
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
Animal Drugs
FDA approved animal drugs -> Active ingredient
Pharmaceuticals -> UK Veterinary Medicines Directorate List
物理化学的性質
- 融点
- 170 · 170-185 C
- 比重(密度)
- 1.5 · 1.5000 (rough estimate)
- 屈折率
- 1.62 · 1.6200 (estimate)
- 貯蔵温度
- 2 · 2-8°C
- 溶解性
- 50 mg/mL · ピリジン:可溶50mg/mL
- 外見
- Solid
- 色
- ホワイトからオフホワイト
- 水溶解度
- 水にわずかに溶ける。プロピレングリコールまたはピリジンに可溶。
- Merck
- 14 · 14,6178
- 主な用途
- 医薬品(低分子化合物)
- 化粧品成分の機能
- 抗菌剤
- InChI
- InChI=1S/C18H14Cl4N2O.HNO3/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22;2-1(3)4/h1-8,11,18H,9-10H2;(H,2,3,4)
- InChIKey
- MCCACAIVAXEFAL-UHFFFAOYSA-N
- SMILES
- C(C1C=CC(=CC=1Cl)Cl)(OCC1C=CC(=CC=1Cl)Cl)CN1C=NC=C1.N(O)(=O)=O
- CAS データベース
- 22832 · 22832-87-7(CAS DataBase Reference)
化学的性質
化学的特性White Solid
安全と法規制
GHS分類
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P321, P330, P333+P317, P337+P317, P362+P364, P391, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 161 reports by companies from 14 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
危険有害性情報
Regulatory Information
REACH registered substance: Miconazole nitrate (EC: 245-256-6)
Miconazole nitrate: Does not have an individual approval but may be used under an appropriate group standard
毒性情報
Toxicity Summary
Miconazole interacts with 14-α demethylase, a cytochrome P-450 enzyme necessary to convert lanosterol to ergosterol. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Miconazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms, inhibit purine uptake, and impair triglyceride and/or phospholipid biosynthesis.
安全データ
- wgk
- 3
- rtecs
- NI4771000
- ridadr
- 3249
- hs_code
- 2933290000
- risk_code
- 22-43-40
- hazard_code
- Xn
- safety_code
- 36/37
- hazard_class
- 6.1(b)
- packing_group
- III
- Hazard Classifications
- Acute Tox. 4 OralSkin Sens. 1
- ストレージクラス
- 11 - Combustible Solids
化学と産業
薬理情報
FDA Pharmacological Classification
2% MICONAZOLE NITRATE CREAM
Azoles [CS]; Azole Antifungal [EPC]
ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE
Azole Antifungal [EPC]; Azoles [CS]
ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE
Azoles [CS]; Azole Antifungal [EPC]
MeSH Pharmacological Classification
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.
Compounds that specifically inhibit STEROL 14-DEMETHYLASE. A variety of azole-derived ANTIFUNGAL AGENTS act through this mechanism.
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C9.
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A.
用途と製造
Uses
For topical application in the treatment of tinea pedis (athlete’s foot), tinea cruris, and tinea corporis caused by <i>Trichophyton rubrum</i>, <i>Trichophyton mentagrophytes</i>, and <i>Epidermophyton floccosum</i>, in the treatment of cutaneous candidiasis (moniliasis), and in the treatment of tinea versicolor.
応用分野
用途薬理研究用
用途イミダゾール系抗菌剤です。 広い抗菌スペクトルを示し、各種真菌に対し て強い抗菌作用を示します。
説明Miconazole is a widely used antifungal imidazole that acts by inhibiting the 14α-demethylation of lanosterol, which consequently leads to the inhibition of ergosterol synthesis in fungal cell membranes. Additionally, miconazole has been shown to induce reactive oxygen species in fungal biofilms, demonstrating a MIC value of ≥256 μM against Candida spp.
使用Antifungal (topical).
一般的な説明Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Miconazole nitrate is an imidazole derivative and a broad spectrum antifungal drug used in the management of fungal outbreak in humans and veterinary animals.
上流・下流製品情報
上流原料
サプライヤー100 社
関連反応
化合物ノート
読み込み中…